Cell cycle-dependent resistance or sensitivity to drugs and the importance of MITF genes in melanoma
The toxicities associated with immunotherapy in lung cancer patients
Why should physicians and patients be educated about novel drugs?
Treatment options for stage III melanoma patients
The role of lymphangiogenesis in melanoma